Integrated Pharmaceuticals, Inc. (INTP) Research

Integrated Pharmaceuticals, Inc., established in 1969 and based in Fitchburg, Massachusetts, operates across the United States, focusing on the creation and manufacturing of specialized chemicals and nutritional supplements. The company's diverse portfolio includes compounds and nutraceuticals scientifically proven to offer therapeutic or nutritive benefits for humans, plants, and animals. It also pioneers advancements in production methods for potent pharmaceutical ingredients, encompassing active small molecular drugs and products derived from recombinant DNA technology. Additionally, Integrated Pharmaceuticals supplies calcium enrichments designed for integration into a wide array of consumables, such as soft drinks, coffee, tea, soups, powdered sauces, various other beverages, and enhanced bottled water. Its products are distributed via a network of wholesale distributors and direct-to-consumer retailers. The firm adopted its current name in September 2011, having previously operated as Digital Caddies, Inc.

Open Integrated Pharmaceuticals, Inc. (INTP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.